STOK
STOK
US86150R1077
Stoke Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.6B EUR
2.04B EUR
2.03B EUR
1.87B EUR
Enterprise Value
1.26B EUR
1.93B EUR
1.87B EUR
1.79B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.04x
--
--
--
Price to Sales
57.86x
74.01x
63.17x
72.34x
Price to Book
4.47x
5.91x
5.13x
5.31x
EV/Revenue
45.5x
70.09x
58.4x
69.2x
EV/EBITDA
-5.66x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.65%
-8.85%
-7.29%
-4.64%
ende